Arena Pharmaceuticals, Inc. Stock Split Ratio
Arena Pharmaceuticals, Inc. reported Stock Split Ratio of 10.00% for the 12-month period ending 2018-12-31, per its 10-K filed 2019-02-28.
Discontinued › Notes › Equity › Stockholders' Equity Note
us-gaap:StockholdersEquityNoteStockSplitConversionRatio1 · last filed 2019-02-28
- Arena Pharmaceuticals, Inc. stockholders' equity note, stock split, conversion ratio for fiscal 2018 was 10.00%, a 0.00% change from fiscal 2017.
- Arena Pharmaceuticals, Inc. stockholders' equity note, stock split, conversion ratio for fiscal 2017 was 10.00%.
| Period end | Stockholders' Equity Note, Stock Split, Conversion Ratio 0 month | Stockholders' Equity Note, Stock Split, Conversion Ratio 12 month |
|---|---|---|
| 2018-12-31 | 10.00% 10-K · filed 2019-02-28 | |
| 2017-12-31 | 10.00% 10-K · filed 2018-03-14 | |
| 2017-06-14 | 10.00% 10-Q · filed 2018-05-09 |